ÍâÖÜѪÓÉÓڲɼ¯ÄѶÈС£¬Ò»Ö±ÊǼ²²¡±êÖ¾ÎïÑо¿ºÍÁÙ´²Õï¶ÏÓ¦ÓõÄÖ÷ÒªÔØÌå¡£ÍâÖÜѪµ°°×±êÖ¾ÎïµÄ¼ì²â¸üÊÇÄܹ»¼à¿Ø¼²²¡µÄ¶¯Ì¬±ä»¯£¬³ÉΪÖ÷ÒªµÄ±êÖ¾ÎïÀàÐÍ¡£ÓÈÆäÊǶÔÓÚ·ÇÖ×Áö¼²²¡£¬ÔÚûÓÐCTCϸ°ûºÍctDNA×÷ΪЭͬ±êÖ¾ÎïµÄÇ°ÌáÏ£¬ÍâÖÜѪÖе°°×±êÖ¾ÎïµÄɸѡÓë¼ì²â¾ÍÏÔµÃÓÈΪÖØÒª¡£

      È»¶ø£¬ÍâÖÜѪÖеĵ°°×Öʸ߶ȸ´ÔÓ£¬¶¯Ì¬·¶Î§´ï11-12¸öÊýÁ¿¼¶£¬¼ÈÓÐÒÔ°×µ°°×£¨Albumin£©Îª´ú±íµÄmg¼¶µÄ¸ß·á¶Èµ°°×ÖÊ£¨Õ¼¾ÝÍâÖÜѪ×ܵ°°×ÖÊÁ¿µÄ99%£©£¬ÓÖÓÐÒÔϸ°ûÒò×ÓΪ´ú±íµÄfg¼¶µ°°×ÖÊ¡£Òò´Ë£¬¶ÔÓÚÍâÖÜѪµ°°×±êÖ¾ÎïµÄɸѡºÍÑо¿Ò²³äÂú×ÅÌôÕ½¡£

 

 

 

 

 

     Ò»°ãÇé¿öÏ£¬¶ÔÓÚ¸´Ôӵĵ°°×ÖʵÄɸѡÀ´Ëµ£¬ÒºÏàÉ«Æ×-ÖÊÆ×´®Áª£¨LC-MS/MS£©¼¼Êõ³ÉΪÊ×Ñ¡¡£È»¶ø£¬³£¹æLC-MS/MS¼¼Êõ»ùÓÚbottom-upµÄɸѡ²ßÂÔ£¨½«ËùÓе°°×ÖÊÎÞ²î±ðµÄø½â³É¶àëĺó£¬Í¬²½½øÈëÖÊÆ×½øÐмì²â£©£¬ÔÚ´óÁ¿¸ß·á¶Èµ°°×´æÔÚµÄÇé¿öÏ£¬LC-MS/MSÍùÍù»á¸üÇãÏòÓÚ¼ì³ö¸ß·á¶Èµ°°×ÖÊ£¬¶ÔÓÚng¼¶ÒÔϵĵͷá¶Èµ°°×ÖÊ£¨ÓÈÆäÊÇIL-1β¡¢IL-6¡¢INF-γµÈÖØҪϸ°ûÒò×Ó£©µÄ¼ì²âÄÜÁ¦ÑÏÖز»×ã¡£

      ͬʱ£¬ÍâÖÜѪÖеĵ°°×ÖÊÀ´Ô´·á¸»£¬¼ÈÓÐϸ°ûµòÍöÍÑÂäµÄ±íÃæµ°°×£¬Ò²ÓÐϸ°ûÖ÷¶¯·ÖÃÚµÄϸ°ûÒò×Ó£¬»¹ÓжàÖÖϸ°û·ÖÃÚµÄÍâÃÚÌåËùЯ´øµÄµ°°×ÖʵÈ¡£¾­¹ý´óÁ¿ÊµÑéÊý¾ÝÀÛ»ý£¬ÎÒÃÇ·¢ÏÖÔÚÍâÖÜѪµ°°×ÖÊ×éÑо¿Èç¹û½öÓô«Í³µÄLC-MS/MSʵÑé·½°¸½øÐÐɸÑ¡£¬Êý¾ÝʼÖÕÊÇƬÃæµÄ¡£Í¬ÑùµÄѪ½¬ÑùÆ·£¬ÓÃLC-MS/MSºÍAntibody Array¼¼ÊõËùɸѡµ½µÄµ°°×ÖÖÀàºÍ¹¦ÄÜÀà±ð½»²æÐÔºÜÉÙ£¬¶øÍâÃÚÌåЯ´øµÄµ°°×ÖʼÈÓëѪ½¬totalµ°°××é¼ì³öÊý¾ÝÓÐÒ»¶¨µÄ½»¼¯¡£Í¬Ê±£¬¶ÔÓÚÌض¨ÀàÐ͵ĵ°°×ÖÊ£¬ÍâÃÚÌåÒ²¾ßÓÐÏÔÖøµÄ¸»¼¯Ð§¹û£¨ÈçÏÂͼ£©£º

|   k8¿­·¢(Öйú)ÍâÖÜѪµ°°×ÖÊ×éѧ·ÖÎö

      Ϊ»ñµÃ¸ßÖÊÁ¿µÄÍâÖÜѪµ°°×ÖÊ×éÊý¾Ý£¬k8¿­·¢(Öйú)ÔÚ¼ì²â·½·¨ÉϽøÐÐÁË´´ÐÂÉý¼¶£¬ÒÔ¾¡¿ÉÄܹ۲⵽ÍâÖÜѪµ°°×ÖÊ×éµÄÈ«Æ×£¬ÐγÉÁ˶ÀÌصÄÍâÃÚÌåµ°°××é“1+1+1”Ìåϵ¡£

¡ñ   Ê×ÏÈ£¬ÀûÓÃFAIMSºÍTIMSΪ´ú±íµÄ4DÖÊÆ×Ô¤´¦Àí×°Ö㬶ԽøÈëMSÇ°µÄÀë×Ó½øÐÐԤɸÑ¡£¬¼ò³Æ“Àë×Ó¹ýÂË”¡£Í¨¹ýµç³¡ºÍµªÆøÔ´µÄ×ÛºÏ×÷Ó㬽«Ìض¨Àë×ÓÓÈÆäÊÇ1¼ÛÔÓÀë×Ó½øÐÐÓÐЧȥ³ý£¬Ìá¸ß½øÈëÖÊÆ×ÒǵÄÀë×Ó´¿¶È£¬½ø¶øÔÚ´«Í³LC-MS/MS¼ø¶¨Éî¶ÈµÄ»ù´¡ÉÏÔÙÌá¸ß10%-20%µÄ¼ø¶¨µ°°×Æס£

¡ñ   ½øÒ»²½£¬k8¿­·¢(Öйú)ÀûÓÃÌØÉ«µÄ¿¹ÌåоƬ¼¼Êõ¶ÔÓÚLC-MS/MSËù²»ÄÜʶ±ðµÄ·ÖÃÚµ°°×ÀàÐͽøÐв¹³ä¼ø¶¨£¬Ò»´ÎÐÔ¿ÉÌØÒìÐԵļì²â500+ÖÖµ°°×ÖÊ£¬¼«´óµØ·á¸»ÁËÍâÖÜѪµÍ·á¶Èµ°°×Æס£

¡ñ   Í¬Ê±£¬k8¿­·¢(Öйú)ÀûÓÃÔÚÍâÃÚÌ嶨Á¿µ°°×ÖÊ×éѧÉϵÄÓÅÊÆ£¬ÔÚ»ñµÃ¸ß´¿¶ÈÍâÃÚÌåµÄ»ù´¡ÉÏ£¬ÀûÓÃLC-MS/MS¼¼Êõ½øÐÐÉî¶ÈµÄÍâÃÚÌåµ°°×ÖÊ×é½âÎö£¬½«¶ÔÓÚÍâÖÜѪÖеĵ°°×Æ×£¬ÓÈÆäÊÇÍâÃÚÌåЯ´øµÄĸ±¾Ï¸°ûµÄĤµ°°×Æ×½øÐиü¼ÓÈ«ÃæµÄ¸²¸Ç¡£

|   ¾­µä°¸Àý

      ¹ú¼Òµ°°×ÖÊ×éÖÐÐÄÑо¿ÍŶӷ¢ÏÖÒøм²¡ÖÎÁÆÖгÉÒ©“ÒøмÁé”ÔÚÁÙ´²É϶Բ»Í¬»¼ÕßÁÆЧ´æÔÚ²îÒìÐÔ£¬ÎªÔÚÖÎÁÆÇ°°ïÖúÁÙ´²Ò½ÉúÕÒµ½“ÒøмÁ锵ÄÊÊÓ¦»¼Õߣ¬Ñо¿ÈËÔ±ÀûÓÃÉî¶Èµ°°×ÖÊ×éѧ¼¼Êõ£¨LC-MS/MS ½áºÏ Antibody Array£©µÄ²ßÂÔ¿ªÕ¹ÓÃÒ©°éËæ±êÖ¾ÎïÑо¿¡£

      Ñо¿½á¹ûÏÔʾ£ºÀûÓÃLC-MS/MSµÄDIA¼¼Êõɸѡµ½µÄµ°°×ÖÊÓëAntibody Arrayɸѡµ½µÄµ°°×ÖʵÄÖÖÀà¾ßÓÐÃ÷ÏԵķֽçÏߣ¬¼´LC-MS/MSɸѡµ½µÄµ°°×Æ×Ö÷Òª¼¯ÖÐÔÚѪÇåÖÐng¼¶ÒÔÉϵĵ°°×ÖÊȺÌ壬¶øAntibody Arrayɸѡµ½µÄµ°°×Æ×Ö÷Òª¼¯ÖÐÔÚng-pg¼¶µÄµ°°×ÖÊȺÌåÖС£Í¬Ê±£¬Á½ÖÖ¼¼Êõ¾ù·¢ÏÖÁËһЩ“ÒøмÁ锲îÒìÏìÓ¦£¨Responder  vs  Non-responder£©µ°°×ÖÊ£¬×éºÏÁ½ÖÖ¼¼Êõɸѡµ½µÄµ°°×±êÖ¾Îï¿ÉÒÔ¸üΪÓÐЧµØ¶Ô“ÒøмÁ锲îÒìÏìÓ¦»¼Õß½øÐÐÇø·Ö¡£

|   Ïà¹ØÎÄÏ×

[1]. Xihao Du, Qingli Zhang, Yixuan Jiang£¬et al. Dynamic molecular choreography induced by traffic exposure: A randomized, crossover trial using multi-omics profiling. J Hazard Mater. 2022 Feb 15;424(Pt A):127359.£¨¸´µ©´óѧ¹«ÎÀѧԺ Ѫ½¬£©IF=13.6

[2]. Meng Xu, Jingwen Deng, Kaikun Xu, et al. In-depth serum proteomics reveals biomarkers of psoriasis severity and response to traditional Chinese medicine. Theranostics, 2019, 9(9):2475-2488£¨µ°°×ÖÊ×éѧ¹ú¼ÒÖصãʵÑéÊÒ ÑªÇ壩IF=12.4